Macroscopic somatic clonal expansion in morphologically normal human urothelium

Cited by (210)

Items 101–200 of 210

1. Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma
   Lisha Ying, Chunliu Zhang, Alexandre Reuben, Yiping Tian, Jiaoyue Jin, Canming Wang, Jing Bai, Xinyuan Liu, Jianfei Fang, Tingting Feng et al. · 2023 · iScience
2. Role of Chromatin Modifying Complexes and Therapeutic Opportunities in Bladder Cancer
   Khyati A. Meghani, Lauren Folgosa Cooley, Andrea Piunti, Joshua J. Meeks · 2022 · Bladder Cancer
3. Mutational signature and prognosis in adenocarcinoma of the bladder
   Guoliang Yang, Akezhouli Shahatiaili, Shihao Bai, Liyang Wang, Di Jin, Ming Cao, Peipei Su, Qiang Liu, Kun Tao, Qi Long et al. · 2024 · The Journal of Pathology
4. The role of KMT2 gene in human tumors.
   Zhilong Zhang, Peng-Fei Yu, Zhi‐Qiang Ling · 2022 · PubMed
5. Bladder cancer organoids as a functional system to model different disease stages and therapy response
   Martina Minoli, Thomas Cantore, Mirjam Kiener, Tarcisio Fedrizzi, Federico La Manna, Sofia Karkampouna, V. Genitisch, Antonio Rodrı́guez, Irena Klima, Paola Gasperini et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
6. Clonal expansion in normal tissues
   Hirona Maeda, Nobuyuki Kakiuchi · 2024 · Cancer Science
7. Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates
   Uttam Satyal, Henkel Valentine, David Liu, Michael J. Slifker, Costas D. Lallas, Edouard John Trabulsi, Laura Bukavina, Lauren Szeto, Jean H. Hoffman-Censits, Kent William Mouw et al. · 2024 · JCO Precision Oncology
8. Liquid Biopsy-Based Accurate Diagnosis and Genomic Profiling of Hard-to-Biopsy Tumors via Parallel Single-Cell Genomic Sequencing of Exfoliated Tumor Cells
   Ziyuan Zhang, Zhigang Liu, Lin Chen, Zhuo Wang, Yangyang Zhai, Peiyu Qian, Yichun Zhao, Ling Zhu, Haowen Jiang, Xubo Wu et al. · 2024 · Analytical Chemistry
9. Molecular Biology of Bladder Cancer
   David James McConkey · 2021 · Hematology/Oncology Clinics of North America
10. A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients
    Yuto Matsushita, Yuji Iwashita, Shunsuke Ohtsuka, Ippei Ohnishi, Takashi Yamashita, Hideaki Miyake, Haruhiko Sugimura · 2021 · Genes and Environment
11. Case of the Month from the University Hospital of Bern, Switzerland: Urothelial carcinoma in an orthotopic neobladder: reported cases and pathophysiological hypotheses
    Kadri Dadikhi, Felix Mueller, Matteo Montani, George Niklaus Thalmann, Bernhard M. Kiss · 2022 · British Journal of Urology
12. Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis
    Sangkyou Lee, Jolanta E. Bondaruk, Yishan Wang, Huiqin Chen, June Goo Lee, Tadeusz Majewski, Rachel D. Mullen, David E. Cogdell, Jiansong Chen, Ziqiao Wang et al. · 2024 · Cell Reports
13. Does a Novel Mutagenic Process Target KMT2D Mutation in the Most Common First Event on the Path to Bladder Cancer?
    Simon C. Baker, Andrew S. Mason, Jennifer Southgate · 2020 · European Urology
14. Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations
    Ekaterina Laukhtina, Ursula J. Lemberger, Andreas Bruchbacher, Dafina Ilijazi, Stephan M. Korn, Florian Berndl, David D’Andrea, Martin Susani, Dmitry Victorovich Enikeev, Éva Compérat et al. · 2021 · Journal of Personalized Medicine
15. A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues
    Tom Luijts, Kerryn Elliott, Joachim T. Siaw, Joris Van de Velde, Elien Beyls, Arne Claeys, Tim Lammens, Erik Larsson, Wouter Willaert, Anne Vral et al. · 2022 · Scientific Reports
16. Alternative mRNA Splicing Controls the Functions of the Histone H3K27 Demethylase UTX/KDM6A
    2023
17. Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy
    Ryo Yamashita, Masafumi Nakamura, Akifumi Notsu, Koiku Asakura, Kimitsugu Usui, Yuma Sakura, Hideo Shinsaka, Masato Matsuzaki, Takashi Sugino, Ryuichi Mizuno et al. · 2024 · BJUI Compass
18. Single-cell transcriptomic landscape and the microenvironment of normal adjacent tissues in hypopharyngeal carcinoma
    Rui Guan, Ce Li, Fangmeng Gu, Wenming Li, Dongmin Wei, Shengda Cao, Fen Chang, Dapeng Lei · 2024 · BMC Genomics
19. Clonal expansion of cancer driver gene mutants investigated using advanced sequencing technologies
    Barbara L. Parsons · 2024 · Mutation Research/Reviews in Mutation Research
20. Extending the shelf-life of precursor solutions and inhibiting light-induced oxidation of iodides for achieving highly efficient and durable perovskite solar cells
    Weijian Tang, Yu Chen, Ruisen Shi, Yihui Wu, Jingquan Zhang · 2025 · Journal of Materials Chemistry A
21. Genomic and Transcriptomic Profiling of High-risk Bladder Cancer Reveals Diverse Molecular and Microenvironment Ecosystems
    Khyati A. Meghani, Yanni Yu, Noah Frydenlund, Erik Z. Li, Bonnie Choy, Sarki Abba Abdulkadir, Joshua J. Meeks · 2025 · European Urology
22. Identification of key genes in human urothelial cells corresponding to interstitial cystitis/bladder pain syndrome in a lipopolysaccharide‐induced cystitis model
    Liao Peng, Xiaotian Li, Wei Wang, Xiaoshuai Gao, Xiao Zeng, Deyi Luo · 2021 · Neurourology and Urodynamics
23. Effect of subsequent bladder cancer on survival in upper tract urothelial carcinoma patients post-radical nephroureterectomy: a systematic review and meta-analysis
    Haopu Hu, Shicong Lai, Xinwei Tang, Xinwei Tang, Chin‐Hui Lai, Tao Xu, Hao Hu, Hao Hu · 2023 · BMC Urology
24. Molecular Pathology of Urothelial Carcinoma
    Hikmat A Al‐Ahmadie, George Jabboure Netto · 2024 · Clinics in Laboratory Medicine
25. Multisite long-read sequencing reveals the early contributions of somatic structural variations to HBV-related hepatocellular carcinoma tumorigenesis
    Tianfu Zeng, Haotian Liao, Xia Lin, Siyao You, Yanqun Huang, Jiaxun Zhang, Yahui Liu, Xuyan Liu, Dan Xie · 2025 · Genome Research
26. What spatial omics is teaching us about field cancerisation in prostate and bladder cancer
    Matthew H V Byrne, Thineskrishna Anbarasan, Lisa Browning, Dan J. Woodcock · 2025 · British Journal of Urology
27. Heterogeneity of urinary system tumors: novel avenues for targeted therapy and precision medicine
    Hao Chen, Yang Weng, Donghan Zheng, Tian Xiang Li, Nan Xu, Longdan Kang, Liang Feng · 2025 · Journal of Advanced Research
28. Enhancer and metabolic rewiring by KMT2C–COMPASS or KMT2D–COMPASS family loss in cancer creates druggable vulnerabilities
    Zibo Zhao, Ali Shilatifard · 2026 · Nature reviews. Cancer
29. Urothelial carcinoma in situ with “overriding” features can evade detection by mimicking umbrella cells
    Dorukhan H. Bahceci, Jane Nguyen, Ankur R. Sangoi, Bradley A. Stohr, Emily Chan · 2023 · Human Pathology
30. Somatic mutations acquired during life: state of the art and implications for the kidney
    Jean Piero Margaria, Sipontina Faienza, Irene Franco · 2025 · Kidney International
31. Struggle within: evolution and ecology of somatic cell populations
    Bartłomiej Świątczak · 2021 · Cellular and Molecular Life Sciences
32. Epigenetic Enabled Normal Human Cells, Lead to First Cell’s Unique Division System, Driving Tumorigenesis Evolution
    Kirsten H. Walen · 2022 · Journal of Cancer Therapy
33. Clones of aging: When better fitness can be dangerous
    Fabio Marongiu, Samuele Cheri, Ezio Laconi · 2023 · European Journal of Cell Biology
34. Integrative analysis of pancreatic microbiota and metabolome in patients with pancreatic ductal adenocarcinoma
    Yiqing Zhu, Xiao Liang, Feng Li, Jianwei Xu, Changxu Chen, Haoyun Tang, Yifan Wang, Lixiang Li, Luping Xing, Yanyan Dong et al. · 2025 · Scientific Reports
35. DNA mutation rates in evolution, longevity, and disease: An evolutionary and biological trade-off
    DuoYao Cao, ChunBo Zeng, Ruibao Ren · 2026 · Cell investigation.
36. Cu(II) and Zn(II) complexes incorporated with active analogue fragments molecule of the aristolochic acid: Crystal structure and biological activity
    Jing Feng, Ren‐Shu Wang, Yuan-Lan Wang, Yizhu Lei · 2021 · Journal of Molecular Structure
37. Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study
    Zhenkai Luo, Binbin Jiao, Tao Huang, Hang Zhao, Weifeng He, Yuxuan Bo, Zhenshan Ding, Guan Zhang · 2023 · Journal of Cancer Research and Clinical Oncology
38. Comparison of PDD-TURBT alone versus white light TURBT plus intravesical BCG therapy: A propensity-score matching study
    Jimpei Miyakawa, Yuta Yamada, Yuji Hakozaki, Katsuhiro Makino, Jun Kamei, Satoru Taguchi, Taketo Kawai, Yoshiyuki Akiyama, Daisuke Yamada, Haruki Kume · 2024 · Photodiagnosis and Photodynamic Therapy
39. Chemokines and PI3K/AKT signaling pathway mediate the spontaneously ruptured hepatocellular carcinoma through the regulation of the cell cycle
    Yan Zhang, Yang-Liu Zhou, Na Xu, Tao Meng, Zhenzhen Wang, Faming Pan, Lixin Zhu · 2025 · Hepatobiliary & pancreatic diseases international
40. Developing a nomogram for predicting intravesical recurrence after radical nephroureterectomy: a retrospective cohort study of mainland Chinese patients
    Shicong Lai, Xingbo Long, Pengjie Wu, Jianyong Liu, Samuel Seery, Huimin Hou, Ming Liu, Yuan Li, Jianye Wang · 2021 · Japanese Journal of Clinical Oncology
41. The complex genetics of epigenetics in urothelial carcinomas
    Ian J. Frew, H. T. Marc Timmers, Roland Schüle, Christian Gratzke · 2020 · Nature Reviews Urology
42. Imposter among us: field cancerization in the bladder
    Daniel J . Rodden, Ella H. Chung, Rea Pittie, David Tomoaki Miyamoto · 2024 · Translational Andrology and Urology
43. Single‐Cell Sequencing‐Guided Annotation of Rare Tumor Cells for Deep Learning‐Based Cytopathologic Diagnosis of Early Lung Cancer
    Yichun Zhao, Ruoran Qiu, Zhuo Wang, Yunyun Li, Xu Yang, Yanlin Li, Xiaohan Shen, Yun Liu, Ziqiang Chen, Qihan You et al. · 2025 · Advanced Science
44. Nature of spontaneously arising single base substitutions in normal cells
    Shunichi Takeda, Yang Luan · 2021 · Genome Instability & Disease
45. Molecular Characterization of Upper Tract Urothelial Carcinoma for Precision Therapeutics and Non-invasive Diagnostics
    Emiko Sugawara, Kei Koyama, Kentaro Inamura · 2022 · Current Genomics
46. Next-generation sequencing has diagnostic utility in challenging small/flat urothelial lesions
    Amélie Pinard, Constance Chen, Jessica Van Ziffle, Jeffry Simko, Bradley A. Stohr, Emily Chan · 2024 · Annals of Diagnostic Pathology
47. DNA Methylation and Chromatin Regulators in Bladder Cancer
    Wolfgang A. Schulz, Michèle J. Hoffmann · 2024 · Springer eBooks
48. Constructing a prognostic model based on MPT-related genes and investigate the characteristics of immune infiltration in bladder cancer
    Lei Yang, Zhiqiang Zhang, Mengfan Xu, Muhan Shang, Haibing Wang, Zhiqi Liu · 2025 · Discover Oncology
49. Assessing the Influence of Bladder Cancer on Upper Tract Urothelial Carcinoma Prognoses Following Radical Nephroureterectomy: A Retrospective, Propensity Score-Based Multicenter Cohort Study
    Shicong Lai, Pengjie Wu, Jianyong Liu, Yuxuan Song, Samuel Seery, Huanrui Wang, Xing Luo, Hao Hu, Ming Liu, Tao Xu · 2025 · Annals of Surgical Oncology
50. ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
    Zhaopei Liu, Lingkai Zhang, Kaifeng Jin, Han Zeng, Xiaohe Su, Yawei Ding, Jiaxing Sun, Yuzhen Wu, Hailong Liu, Yu Zhu et al. · 2025 · Clinical Cancer Research
51. Comprehensive Collection of Whole-Slide Images and Genomic Profiles for Patients with Bladder Cancer
    Peihang Xu, Tianqi Li, Fengmei Qu, Mingkang Tian, Jun Wang, Hualei Gan, Dingwei Ye, Fei Ren, Yijun Shen · 2024 · Scientific Data
52. Cell-type-specific patterns and consequences of somatic mutation in development and aging brain
    Andrea J. Kriz, Shulin Mao, Diane D. Shao, Daniel A. Snellings, Rebecca Andersen, Guanlan Dong, Chanthia C. Ma, Hayley E. Cline, August Yue Huang, Eunjung Alice Lee et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
53. Mutation Hotspots Found in Bladder Cancer Aid Prediction of Carcinogenic Risk in Normal Urothelium
    Sydney R. Grant, Li Tang, Lei Wei, Barbara A. Foster, György Paragh, Wendy J. Huss · 2023 · International Journal of Molecular Sciences
54. Ultra-sensitive DNA sequencing maps mutations that precede cancer
    Jian Carrot‐Zhang · 2025 · Nature
55. Somatic mutations and clonal evolution in normal tissues and cancer development
    Kenichi Yoshida · 2025 · Experimental & Molecular Medicine
56. Single-cell cloning and its approaches
    Amany E. S. Ammar · 2025 · Frontiers in Cell and Developmental Biology
57. Single-Cell Low-Pass Whole Genome Sequencing of Circulating Tumor Cells
    Zhuo Wang, Qihui Shi · 2026 · Methods in molecular biology
58. Diverse Biological Functions of IGF2BPs in Hepatobiliary Cancers and Their Clinical Relevance
    Zhijie Yin, Qingfu Lang, Peng Xiao, Chen Jia, Jiayu Sun, Tiemin Pei · 2026 · Frontiers in Bioscience-Landmark
59. Real-World Evaluation of Uromonitor® for Bladder Cancer Detection and Surveillance
    Amy Newman, Sasha Hansel, Gareth Gerrard, Llwyd David Orton, Ashish Chandra, Rajesh Nair, Francesco Del Giudice, Youssef Ibrahim, Elsie Ellimah Mensah, Muhammad Shamim Khan et al. · 2026 · Cancers
60. Urinary Biomarkers in Urological Oncology: From Biological Origin to Clinical Decision-Making—A Narrative Review
    Aliya Nurmukhanbetova, Kassymkhan Sultanbekov, Khussan Umurzakov, Zie Gassanov, Altyn Duisenbayeva, Alimkhan Talas, Lazzat Shaikenova, Aidos Bolatov · 2026 · Diagnostics
61. Two-dimensional liquid chromatography based on different modulations for the determination of Aristolochic Acid Ⅰ in Asari Radix et Rhizoma
    Xinyu Tao, Qin-Ling Cao, Yufeng Zhang, Xujia Cai, Min Zhang, Min Zhang, Ping Hu · 2024 · Journal of Chromatography A
62. Inhibiting KDM6A Phosphorylation Suppresses Glycolysis in Oral Squamous Cell Carcinoma
    Xin Chen, Xin Hu, Jun Chen, Yikang Ji, Xinhua Pan, Xu Wang · 2025 · Oral Diseases
63. Centromere organization and epigenetic regulation in Aristolochia fimbriata
    Kunpeng Li, Jie Li, Ran Zhao, Liuyu Qin, Yu Wang, Jieling Ren, Ke Lei, Jianyu Wang, Xin Yi, Yue Zhou et al. · 2026 · Genome biology
64. Single cell spatial transcriptomics track the evolutionary hierarchy and microenvironment remodeling during breast carcinoma invasion
    Di Wang, Qichen Dai, J Z Guo, Dan Li, Changyuan Guo, Peiqing Ma, Feng Wen, Xiangyu Tong, Changhao Gong, H-Y Cheng et al. · 2026 · Nature Communications
65. Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer
    Yuto Matsushita, Asuka Kawakami, Ryo Sato, Kyohei Watanabe, Hiromitsu Watanabe, Keita Tamura, Daisuke Motoyama, Toshiki Ito, Takayuki Sugiyama, Atsushi Otsuka et al. · 2022 · Japanese Journal of Clinical Oncology
66. Urine Biomarkers for Bladder Cancer Diagnosis and Screening
    Richard T. Bryan, Douglas G. Ward · 2024 · Springer eBooks
67. Shedding Light on Mutant Clonal Dynamics and Cancer Risk in the Skin
    Marco De Dominici, James V. DeGregori · 2021 · Cancer Discovery
68. Nephrotoxicity of Natural Products: Aristolochic Acid and Fungal Toxins
    Paraskevi Sotiropoulou, Alexander Zielinski, Daniel Reto Dietrich · 2024 · Elsevier eBooks
69. Primary urothelial carcinoma of the ureter without concurrent renal pelvic or bladder carcinoma: A contemporary clinicopathologic analysis
    Christina M. Gutierrez, Bradley Curtis Carthon, Shreyas Subhash Joshi, Adeboye O. Osunkoya · 2021 · Pathology - Research and Practice
70. Bladder Cancer Genomics: Indications for Sequencing and Diagnostic Implications
    Andrew Thomas Lenis, Eugene J. Pietzak · 2021 · Springer eBooks
71. Pathogenese und molekulare Diagnostik der akuten myeloischen Leukämie
    Alwin Krämer, Christian Thiede · 2022 · Die Onkologie
72. Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview
    Lancelot Seillier, Martin Peifer · 2023 · Methods in molecular biology
73. Additional file 18 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Ning Xu, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Wang, Haixing, Hailiang Zhang, Yuanyuan Qu, Fujiang Xu, Yunzhi Wang, Zhaoyu Qin et al. · 2022 · Figshare
74. Additional file 14 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Ning Xu, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Wang, Haixing, Hailiang Zhang, Yuanyuan Qu, Fujiang Xu, Yunzhi Wang, Zhaoyu Qin et al. · 2022 · Figshare
75. Additional file 15 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Ning Xu, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Wang, Haixing, Hailiang Zhang, Yuanyuan Qu, Fujiang Xu, Yunzhi Wang, Zhaoyu Qin et al. · 2022 · Figshare
76. Additional file 13 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Ning Xu, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Wang, Haixing, Hailiang Zhang, Yuanyuan Qu, Fujiang Xu, Yunzhi Wang, Zhaoyu Qin et al. · 2022 · Figshare
77. Additional file 16 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Wang, Haixing, Hailiang Zhang, Yuanyuan Qu, Fujiang Xu, Yunzhi Wang, Zhaoyu Qin et al. · 2022 · Figshare
78. Additional file 20 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Wang, Haixing, Hailiang Zhang, Yuanyuan Qu, Fujiang Xu, Yunzhi Wang, Zhaoyu Qin et al. · 2022 · Figshare
79. Additional file 17 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Wang, Haixing, Hailiang Zhang, Yuanyuan Qu, Fujiang Xu, Yunzhi Wang, Zhaoyu Qin et al. · 2022 · Figshare
80. Additional file 19 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Ning Xu, Zhenmei Yao, Guoguo Shang, Dingwei Ye, Wang, Haixing, Hailiang Zhang, Yuanyuan Qu, Fujiang Xu, Yunzhi Wang, Zhaoyu Qin et al. · 2022 · Figshare
81. Microenvironment of Normal-Looking Tissues Adjacent to Cancer: Matters Arising
    Mohamed Wishahi · 2024 · Interdisciplinary cancer research
82. Immune Response and Tumor Microenvironment
    Vivek Pazhamalai, V. T. Thanush, P. Dharshika, Kosireddy Vanitha, Albin Richard, Setti Sudharsan Meenambiga · 2024 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
83. Molecular Pathogenesis: Field Cancerization and Clonal Evolution in Urothelial Cancer Initiation and Progression
    David James McConkey, Cathy Lee Mendelsohn, Byron Lee, Colin P. Dinney, Bogdan A. Czerniak · 2024 · Springer eBooks
84. From Normalcy to Neoplasia: Mutational Events During Bladder Tumor Evolution
    Khyati A. Meghani, Joshua J. Meeks · 2024 · Springer eBooks
85. Should follow-up cystoscopy be performed in upper-tract urothelial carcinoma patients managed with radical nephroureterectomy after a five-year bladder tumor-free period?
    Guoli Wang, Bao Guan, Yicong Du, Qi Tang, Chunru Xu, Qian Yang, Hanzhen Ren, Huifeng Zhang, Chao Cao, Kaishun Luo et al. · 2025 · Discover Oncology
86. Screening, Validation, and Machine Learning-Based Evaluation of Serum Protein Biomarkers for Esophageal Squamous Cell Carcinoma Based on Single-Cell Subtype-Specific Genes
    Xiuzhi Zhang, Zhefeng Xiao, Fengqi Chen, Wenke Sun, Tiandong Li, Hua Ye, Peng Wang, Liping Dai, Xiaoli Liu · 2025 · Journal of Proteome Research
87. STAG2 cohesin cooperates with DREAM to maintain quiescence and suppress tumourigenesis in the urothelium
    Maria Ramal, Eleonora Lapi, Mark Kalisz, Jaime Martínez de Villarreal, Meritxell Novillo-Font, Miriam Marqués, Eduardo Zarzuela, Marta Isasa, Osvaldo Graña‐Castro, Jianming Xu et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
88. Additional file 9 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
89. Additional file 8 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
90. Additional file 11 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
91. Additional file 6 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
92. Additional file 12 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
93. Additional file 5 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
94. Additional file 4 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
95. Additional file 1 of Single-cell transcriptomic landscape and the microenvironment of normal adjacent tissues in hypopharyngeal carcinoma
    Rui Guan, Li, Ce, Gu, Fangmeng, Wenming Li, Wei, Dongmin, Cao, Shengda, Fen Chang, Lei, Dapeng · 2024 · Figshare
96. Additional file 7 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Hailiang Zhang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
97. Additional file 3 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
98. Additional file 10 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Hailiang Zhang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
99. Additional file 2 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
    Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Hailiang Zhang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare
100. Additional file 1 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder
     Xu, Ning, Zhenmei Yao, Shang, Guoguo, Ye, Dingwei, Wang, Haixing, Zhang, Hailiang, Qu, Yuanyuan, Xu, Fujiang, Wang, Yunzhi, Qin, Zhaoyu et al. · 2022 · Figshare